Clinical Trial Update: Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the combination of topotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer. The trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED